TY  - JOUR

T1  - Efficacy of selpercatinib as a first-line treatment for
                    <i>RET</i>
                    -fusion positive non-small-cell lung cancer: a novel two-stage Bayesian network meta-analysis

JO  - Journal of Comparative Effectiveness Research

UR  - https://doi.org/10.57264/cer-2026-0006

PY  - 2026/04/29

AU  - Forsyth JE

AU  - Khanal M

AU  - Kiiskinen U

AU  - Jyothi A

AU  - Goel R

AU  - Puri T

AU  - Ren S

AU  - Sonksen MD

AU  - Wang X

AU  - Jen M-H

ED  - 

DO  - DOI: 10.57264/cer-2026-0006

PB  - Becaris Publishing Limited

Y2  - 2026/05/25

ER  -